Thus, impaired GR signaling is considered an important contributor to stress-related disorders, such as major depressive disorders (MDD)4,5, and targeting impaired GR functions is a therapeutic mechanism of different antidepressants6,7. Here, NR3C1 is linked to major depressive disorder.